Take the money when it is available....that's the mantra in biotech. Having JP Morgan as the underwriter is very smart. When the stock gets over 5, then JPM will cover it with a buy rating and we will get the institutional coverage the COR so badly needs.
Go going Stoll....well done.
All of you whinning about the stock price should be viewing this price as a gift.